Bile acids and their receptors: modulators and therapeutic targets in liver inflammation
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bile acids and their receptors: modulators and therapeutic targets in liver inflammation
Authors
Keywords
-
Journal
Seminars in Immunopathology
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-04-13
DOI
10.1007/s00281-022-00935-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Activation of nuclear receptor PXR induces atherogenic lipids and PCSK9 through SREBP2‐mediated mechanism
- (2021) Mikko Karpale et al. BRITISH JOURNAL OF PHARMACOLOGY
- Circulating Bile Acids in Liver Failure Activate TGR5 and Induce Monocyte Dysfunction
- (2021) Julia Leonhardt et al. Cellular and Molecular Gastroenterology and Hepatology
- Downregulation of TGR5 (GPBAR1) in biliary epithelial cells contributes to the pathogenesis of sclerosing cholangitis
- (2021) Maria Reich et al. JOURNAL OF HEPATOLOGY
- The Management of Cholestatic Liver Diseases: Current Therapies and Emerging New Possibilities
- (2021) Marta Mazzetti et al. Journal of Clinical Medicine
- Clinical features of sodium-taurocholate cotransporting polypeptide deficiency in pediatric patients: case series and literature review
- (2021) Ting-Ting Zou et al. Translational Pediatrics
- FXR in liver physiology: Multiple faces to regulate liver metabolism
- (2021) Katrin Panzitt et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- 24-Norursodeoxycholic acid reshapes immunometabolism in CD8+ T cells and alleviates hepatic inflammation
- (2021) Ci Zhu et al. JOURNAL OF HEPATOLOGY
- DARK AND BRIGHT SIDE OF TARGETING THE FIBROBLAST GROWTH FACTOR RECEPTOR 4 IN THE LIVER
- (2021) Raffaella Maria Gadaleta et al. JOURNAL OF HEPATOLOGY
- Gut microbiota-mediated secondary bile acids regulate dendritic cells to attenuate autoimmune uveitis through TGR5 signaling
- (2021) Jianping Hu et al. Cell Reports
- TGR5 protects against cholestatic liver disease via suppressing the NF-κB pathway and activating the Nrf2/HO-1 pathway
- (2021) Haojun Yang et al. Annals of Translational Medicine
- Maralixibat: First Approval
- (2021) Matt Shirley DRUGS
- The spectrum of Progressive Familial Intrahepatic Cholestasis diseases: Update on pathophysiology and emerging treatments
- (2021) Antonia Felzen et al. European Journal of Medical Genetics
- TGR5 promotes cholangiocarcinoma by interacting with mortalin
- (2020) Ai-Di Li et al. EXPERIMENTAL CELL RESEARCH
- Cholangiocyte-Derived Exosomal lncRNA H19 Promotes Macrophage Activation and Hepatic Inflammation under Cholestatic Conditions
- (2020) Xiaojiaoyang Li et al. Cells
- Pregnane X Receptor Activator Rifampin Increases Blood Pressure and Stimulates Plasma Renin Activity
- (2020) Fatemeh Hassani‐Nezhad‐Gashti et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- A randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitis
- (2020) Kris V. Kowdley et al. JOURNAL OF HEPATOLOGY
- Bile acid-based therapies for non-alcoholic steatohepatitis and alcoholic liver disease
- (2020) Tiangang Li et al. Hepatobiliary Surgery and Nutrition
- Ileal bile acid transporter inhibition as an anticholestatic therapeutic target in biliary atresia and other cholestatic disorders
- (2020) Saul J. Karpen et al. Hepatology International
- Obeticholic acid improves hepatic bile acid excretion in patients with primary biliary cholangitis
- (2020) Kristoffer Kjærgaard et al. JOURNAL OF HEPATOLOGY
- Compound 18 Improves Glucose Tolerance in a Hepatocyte TGR5-dependent Manner in Mice
- (2020) Marlena M. Holter et al. Nutrients
- INT-777 attenuates NLRP3-ASC inflammasome-mediated neuroinflammation via TGR5/cAMP/PKA signaling pathway after subarachnoid hemorrhage in rats
- (2020) Xiao Hu et al. BRAIN BEHAVIOR AND IMMUNITY
- Hepatic NFAT signaling regulates the expression of inflammatory cytokines in cholestasis
- (2020) Shi-Ying Cai et al. JOURNAL OF HEPATOLOGY
- PXR Functionally Interacts with NF-κB and AP-1 to Downregulate the Inflammation-Induced Expression of Chemokine CXCL2 in Mice
- (2020) Maya Okamura et al. Cells
- Gut microbiome, liver immunology, and liver diseases
- (2020) Rui Wang et al. Cellular & Molecular Immunology
- The nonsteroidal FXR agonist cilofexor (GS-9674) improves markers of cholestasis and liver injury in patients with PSC
- (2019) Michael Trauner et al. HEPATOLOGY
- TGR5-dependent hepatoprotection through the regulation of biliary epithelium barrier function
- (2019) Grégory Merlen et al. GUT
- Long non‐coding RNA H19 contributes to cholangiocyte proliferation and cholestatic liver fibrosis in biliary atresia
- (2019) Yongtao Xiao et al. HEPATOLOGY
- Blocking sodium‐taurocholate cotransporting polypeptide stimulates biliary cholesterol and phospholipid secretion
- (2019) Reinout L.P. Roscam Abbing et al. HEPATOLOGY
- Genistein protects against DSS-induced colitis by inhibiting NLRP3 inflammasome via TGR5-cAMP signaling
- (2019) Yu Chen et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Long-term efficacy and safety of obeticholic acid for patients with primary biliary cholangitis: 3-year results of an international open-label extension study
- (2019) Michael Trauner et al. Lancet Gastroenterology & Hepatology
- A Human-like Bile Acid Pool Induced by Deletion of Cyp2c70 Modulates Effects of Farnesoid X Receptor Activation in Mice
- (2019) Jan Freark de Boer et al. JOURNAL OF LIPID RESEARCH
- CONTROL: A randomized phase 2 study of obeticholic acid and atorvastatin on lipoproteins in nonalcoholic steatohepatitis patients
- (2019) Paul J. Pockros et al. LIVER INTERNATIONAL
- TGF-β induced chemoresistance in liver cancer is modulated by xenobiotic nuclear receptor PXR
- (2019) Ella Bhagyaraj et al. CELL CYCLE
- Long-Term Obeticholic Acid Therapy Improves Histological Endpoints in Patients With Primary Biliary Cholangitis
- (2019) Christopher L. Bowlus et al. Clinical Gastroenterology and Hepatology
- The G Protein-Coupled Bile Acid Receptor TGR5 (Gpbar1) Modulates Endothelin-1 Signaling in Liver
- (2019) Caroline Klindt et al. Cells
- Effects of Farnesiferol B on Ischemia-Reperfusion-Induced Renal Damage, Inflammation, and NF-κB Signaling
- (2019) Lu Zhang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Pathophysiologic implications of innate immunity and autoinflammation in the biliary epithelium
- (2018) Mario Strazzabosco et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Bile acid receptors in the biliary tree: TGR5 in physiology and disease
- (2018) Kathleen Deutschmann et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Differential effects of FXR or TGR5 activation in cholangiocarcinoma progression
- (2018) O. Erice et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- The Roles of Xenobiotic Receptors: Beyond Chemical Disposition
- (2018) Bryan Mackowiak et al. DRUG METABOLISM AND DISPOSITION
- Na+ -taurocholate cotransporting polypeptide inhibition has hepatoprotective effects in cholestasis in mice
- (2018) Davor Slijepcevic et al. HEPATOLOGY
- GW4064 attenuates lipopolysaccharide‑induced hepatic inflammation and apoptosis through inhibition of the Toll‑like receptor 4‑mediated p38 mitogen‑activated protein kinase signaling pathway in mice
- (2018) Hsuan‑Miao Liu et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Early assessment of safety and efficacy of tropifexor, a potent non bile-acid FXR agonist, in patients with primary biliary cholangitis: An interim analysis of an ongoing phase 2 study
- (2018) C. Schramm et al. JOURNAL OF HEPATOLOGY
- Effects of Farnesoid X Receptor Activation on Arachidonic Acid Metabolism, NF-kB Signaling, and Hepatic Inflammation
- (2018) Zhibo Gai et al. MOLECULAR PHARMACOLOGY
- Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases
- (2018) Keith D. Lindor et al. HEPATOLOGY
- Bile micro-infarcts in cholestasis are initiated by rupture of the apical hepatocyte membrane and cause shunting of bile to sinusoidal blood
- (2018) Ahmed Ghallab et al. HEPATOLOGY
- Bile Acids Activated Receptors Regulate Innate Immunity
- (2018) Stefano Fiorucci et al. Frontiers in Immunology
- Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trial
- (2018) Gideon M. Hirschfield et al. JOURNAL OF HEPATOLOGY
- FXR agonist obeticholic acid induces liver growth but exacerbates biliary injury in rats with obstructive cholestasis
- (2018) Rowan F. van Golen et al. Scientific Reports
- Suppression of Hepatic Bile Acid Synthesis by a non-tumorigenic FGF19 analogue Protects Mice from Fibrosis and Hepatocarcinogenesis
- (2018) Raffaella Maria Gadaleta et al. Scientific Reports
- TGR5 contributes to hepatic cystogenesis in rodents with polycystic liver diseases through cyclic adenosine monophosphate/Gαs signaling
- (2017) Tatyana V. Masyuk et al. HEPATOLOGY
- New therapeutic concepts in bile acid transport and signaling for management of cholestasis
- (2017) Michael Trauner et al. HEPATOLOGY
- The role of sphingosine 1-phosphate receptor 2 in bile-acid-induced cholangiocyte proliferation and cholestasis-induced liver injury in mice
- (2017) Yongqing Wang et al. HEPATOLOGY
- The ascending pathophysiology of cholestatic liver disease
- (2017) Peter L.M. Jansen et al. HEPATOLOGY
- Biliary bile acids in hepatobiliary injury – What is the link?
- (2017) Peter Fickert et al. JOURNAL OF HEPATOLOGY
- nor Ursodeoxycholic acid improves cholestasis in primary sclerosing cholangitis
- (2017) Peter Fickert et al. JOURNAL OF HEPATOLOGY
- The Bile Acid Receptor GPBAR1 Regulates the M1/M2 Phenotype of Intestinal Macrophages and Activation of GPBAR1 Rescues Mice from Murine Colitis
- (2017) Michele Biagioli et al. JOURNAL OF IMMUNOLOGY
- Effect of ileal bile acid transporter inhibitor GSK2330672 on pruritus in primary biliary cholangitis: a double-blind, randomised, placebo-controlled, crossover, phase 2a study
- (2017) Vinod S Hegade et al. LANCET
- PXR: More Than Just a Master Xenobiotic Receptor
- (2017) Peter O. Oladimeji et al. MOLECULAR PHARMACOLOGY
- Obeticholic acid protects against carbon tetrachloride-induced acute liver injury and inflammation
- (2017) Da-Gang Zhang et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Non-cell-autonomous activation of IL-6/STAT3 signaling mediates FGF19-driven hepatocarcinogenesis
- (2017) Mei Zhou et al. Nature Communications
- Clinical relevance of the bile acid receptor TGR5 in metabolism
- (2017) F Samuel van Nierop et al. Lancet Diabetes & Endocrinology
- Bile Acids Control Inflammation and Metabolic Disorder through Inhibition of NLRP3 Inflammasome
- (2016) Chuansheng Guo et al. IMMUNITY
- Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis
- (2016) Anna Baghdasaryan et al. JOURNAL OF HEPATOLOGY
- Obeticholic Acid Protects against Lipopolysaccharide-Induced Fetal Death and Intrauterine Growth Restriction through Its Anti-Inflammatory Activity
- (2016) Yuan-Hua Chen et al. JOURNAL OF IMMUNOLOGY
- A Novel Small Molecule Activator of Nuclear Receptor SHP Inhibits HCC Cell Migration via Suppressing Ccl2
- (2016) Z. Yang et al. MOLECULAR CANCER THERAPEUTICS
- A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
- (2016) Frederik Nevens et al. NEW ENGLAND JOURNAL OF MEDICINE
- Activation of necroptosis in human and experimental cholestasis
- (2016) Marta B Afonso et al. Cell Death & Disease
- Pregnane X Receptor Regulates Pathogen-Induced Inflammation and Host Defense against an Intracellular Bacterial Infection through Toll-like Receptor 4
- (2016) Zhijuan Qiu et al. Scientific Reports
- TGR5, Not Only a Metabolic Regulator
- (2016) Cong Guo et al. Frontiers in Physiology
- Bcl2 is a critical regulator of bile acid homeostasis by dictating Shp and lncRNA H19 function
- (2016) Yuxia Zhang et al. Scientific Reports
- Cystathionine γ-lyase, a H2S-generating enzyme, is a GPBAR1-regulated gene and contributes to vasodilation caused by secondary bile acids
- (2015) Barbara Renga et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- TGR5 in the Cholangiociliopathies
- (2015) Tatyana V. Masyuk et al. DIGESTIVE DISEASES
- The Cholangiocyte Glycocalyx Stabilizes the �Biliary HCO3- Umbrella': An Integrated Line of Defense against Toxic Bile Acids
- (2015) Lucas J. Maillette de Buy Wenniger et al. DIGESTIVE DISEASES
- Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid
- (2015) Gideon M. Hirschfield et al. GASTROENTEROLOGY
- TGR5 is essential for bile acid-dependent cholangiocyte proliferation in vivo and in vitro
- (2015) Maria Reich et al. GUT
- Pharmacological inhibition of apical sodium-dependent bile acid transporter changes bile composition and blocks progression of sclerosing cholangitis in multidrug resistance 2 knockout mice
- (2015) Alexander G. Miethke et al. HEPATOLOGY
- Impaired uptake of conjugated bile acids and hepatitis b virus pres1-binding in na+-taurocholate cotransporting polypeptide knockout mice
- (2015) Davor Slijepcevic et al. HEPATOLOGY
- Engineered fibroblast growth factor 19 reduces liver injury and resolves sclerosing cholangitis in Mdr2 -deficient mice
- (2015) Mei Zhou et al. HEPATOLOGY
- Tissue-based map of the human proteome
- (2015) M. Uhlen et al. SCIENCE
- Small heterodimer partner interacts with NLRP3 and negatively regulates activation of the NLRP3 inflammasome
- (2015) Chul-Su Yang et al. Nature Communications
- Bile acids induce hepatic differentiation of mesenchymal stem cells
- (2015) Iris Sawitza et al. Scientific Reports
- The glucocorticoid mometasone furoate is a novel FXR ligand that decreases inflammatory but not metabolic gene expression
- (2015) Ingrid T. G. W. Bijsmans et al. Scientific Reports
- Reversal of Endothelial Dysfunction by GPBAR1 Agonism in Portal Hypertension Involves a AKT/FOXOA1 Dependent Regulation of H2S Generation and Endothelin-1
- (2015) Barbara Renga et al. PLoS One
- FXR and liver carcinogenesis
- (2014) Xiong-fei Huang et al. ACTA PHARMACOLOGICA SINICA
- A dysregulated acetyl/SUMO switch of FXR promotes hepatic inflammation in obesity
- (2014) D.-H. Kim et al. EMBO JOURNAL
- Symbiotic Bacterial Metabolites Regulate Gastrointestinal Barrier Function via the Xenobiotic Sensor PXR and Toll-like Receptor 4
- (2014) Madhukumar Venkatesh et al. IMMUNITY
- The critical role of myeloid-derived suppressor cells and FXR activation in immune-mediated liver injury
- (2014) Haiyan Zhang et al. JOURNAL OF AUTOIMMUNITY
- TGR5 reduces macrophage migration through mTOR-induced C/EBPβ differential translation
- (2014) Alessia Perino et al. JOURNAL OF CLINICAL INVESTIGATION
- Intestinal transport and metabolism of bile acids
- (2014) Paul A. Dawson et al. JOURNAL OF LIPID RESEARCH
- G-Protein-Coupled Bile Acid Receptor 1 (GPBAR1, TGR5) Agonists Reduce the Production of Proinflammatory Cytokines and Stabilize the Alternative Macrophage Phenotype
- (2014) Klemens Högenauer et al. JOURNAL OF MEDICINAL CHEMISTRY
- A nontumorigenic variant of FGF19 treats cholestatic liver diseases
- (2014) J. Luo et al. Science Translational Medicine
- FXR agonist GW4064 alleviates endotoxin-induced hepatic inflammation by repressing macrophage activation
- (2014) Jun Yao WORLD JOURNAL OF GASTROENTEROLOGY
- Mechanisms of STAT3 activation in the liver of FXR knockout mice
- (2013) Guodong Li et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Ciliary subcellular localization of TGR5 determines the cholangiocyte functional response to bile acid signaling
- (2013) Anatoliy I. Masyuk et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Bile Acid Receptor TGR5 Agonism Induces NO Production and Reduces Monocyte Adhesion in Vascular Endothelial Cells
- (2013) Taiki Kida et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Gut Microbiota Regulates Bile Acid Metabolism by Reducing the Levels of Tauro-beta-muricholic Acid, a Naturally Occurring FXR Antagonist
- (2013) Sama I. Sayin et al. Cell Metabolism
- Pregnane X Receptor Agonists Impair Postprandial Glucose Tolerance
- (2013) J Rysä et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The receptor TGR5 protects the liver from bile acid overload during liver regeneration in mice
- (2013) Noémie Péan et al. HEPATOLOGY
- TGR5 signalling inhibits the production of pro-inflammatory cytokines byin vitrodifferentiated inflammatory and intestinal macrophages in Crohn's disease
- (2013) Kazuaki Yoneno et al. IMMUNOLOGY
- The TGR5 receptor mediates bile acid–induced itch and analgesia
- (2013) Farzad Alemi et al. JOURNAL OF CLINICAL INVESTIGATION
- Bile acids PKA-dependently induce a switch of the IL-10/IL-12 ratio and reduce proinflammatory capability of human macrophages
- (2013) Katrin Haselow et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Osteopontin is an initial mediator of inflammation and liver injury during obstructive cholestasis after bile duct ligation in mice
- (2013) Min Yang et al. TOXICOLOGY LETTERS
- Downregulation of nuclear receptor FXR is associated with multiple malignant clinicopathological characteristics in human hepatocellular carcinoma
- (2012) Hongying Su et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- FXR ligands protect against hepatocellular inflammation via SOCS3 induction
- (2012) Zhizhen Xu et al. CELLULAR SIGNALLING
- No Correlation between the Expression of FXR and Genes Involved in Multidrug Resistance Phenotype of Primary Liver Tumors
- (2012) P. Martinez-Becerra et al. MOLECULAR PHARMACEUTICS
- Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR
- (2012) Anna C. Calkin et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Bile Acids Induce Inflammatory Genes in Hepatocytes
- (2011) Katryn Allen et al. AMERICAN JOURNAL OF PATHOLOGY
- Activation of bile salt nuclear receptor FXR is repressed by pro-inflammatory cytokines activating NF-κB signaling in the intestine
- (2011) Raffaella M. Gadaleta et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Secreted blood reporters: Insights and applications
- (2011) Bakhos A. Tannous et al. BIOTECHNOLOGY ADVANCES
- TGR5 Activation Inhibits Atherosclerosis by Reducing Macrophage Inflammation and Lipid Loading
- (2011) Thijs W.H. Pols et al. Cell Metabolism
- Selective Activation of Nuclear Bile Acid Receptor FXR in the Intestine Protects Mice Against Cholestasis
- (2011) Salvatore Modica et al. GASTROENTEROLOGY
- Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease
- (2011) R. M. Gadaleta et al. GUT
- A biliary HCO3−umbrella constitutes a protective mechanism against bile acid-induced injury in human cholangiocytes
- (2011) Simon Hohenester et al. HEPATOLOGY
- The G-Protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor kappa light-chain enhancer of activated B cells (NF-κB) in mice
- (2011) Yan-Dong Wang et al. HEPATOLOGY
- Dual farnesoid X receptor/TGR5 agonist INT-767 reduces liver injury in the Mdr2 −/− (Abcb4 −/− ) mouse cholangiopathy model by promoting biliary HCO 3− output
- (2011) Anna Baghdasaryan et al. HEPATOLOGY
- Monocyte chemoattractant protein-1 derived from biliary innate immunity contributes to hepatic fibrogenesis
- (2011) K. Harada et al. JOURNAL OF CLINICAL PATHOLOGY
- FXR and PXR: Potential therapeutic targets in cholestasis
- (2011) Johan W. Jonker et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Effect of bile duct ligation on bile acid composition in mouse serum and liver
- (2011) Youcai Zhang et al. LIVER INTERNATIONAL
- The G Protein-Coupled Bile Acid Receptor, TGR5, Stimulates Gallbladder Filling
- (2011) Tingting Li et al. MOLECULAR ENDOCRINOLOGY
- NF-κB and STAT3 – key players in liver inflammation and cancer
- (2010) Guobin He et al. CELL RESEARCH
- Mutational Characterization of the Bile Acid Receptor TGR5 in Primary Sclerosing Cholangitis
- (2010) Johannes R. Hov et al. PLoS One
- Reciprocal regulation of the bile acid-activated receptor FXR and the interferon-γ-STAT-1 pathway in macrophages
- (2009) Barbara Renga et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- The membrane-bound bile acid receptor TGR5 is localized in the epithelium of human gallbladders
- (2009) Verena Keitel et al. HEPATOLOGY
- Bile acids: regulation of synthesis
- (2009) John Y. L. Chiang JOURNAL OF LIPID RESEARCH
- Partial External Biliary Diversion in Children With Progressive Familial Intrahepatic Cholestasis and Alagille Disease
- (2009) Huiqi Yang et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- Compensatory Induction of Liver Efflux Transporters in Response to ANIT-Induced Liver Injury Is Impaired in FXR-Null Mice
- (2009) Yue J. Cui et al. TOXICOLOGICAL SCIENCES
- Expression and function of the bile acid receptor TGR5 in Kupffer cells
- (2008) Verena Keitel et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Bile Acids: Chemistry, Pathochemistry, Biology, Pathobiology, and Therapeutics
- (2008) A. F. Hofmann et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Farnesoid X receptor antagonizes nuclear factor κB in hepatic inflammatory response
- (2008) Yan-Dong Wang et al. HEPATOLOGY
- Hepatoprotective role of PXR activation and MRP3 in cholic acid-induced cholestasis
- (2007) S Teng et al. BRITISH JOURNAL OF PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search